Natera's Stock Drops: Competition and Patent Battles Intensify
Update: 2025-09-10
Description
Natera's stock dipped after Exact Sciences launched a new cancer detection test, intensifying competition in the genetic testing market. This follows a recent patent lawsuit loss, adding pressure on Natera. Despite these challenges, Natera's stock remains up year-to-date, reflecting long-term growth potential. Is this a buying opportunity or a sign of tougher times ahead for Natera?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
